MRNA Moderna, Inc.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$9.90B
Revenue (FY)
$1.94B 2025-12-31
Net Income (FY)
$-2.82B
American biotechnology company.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
American biotechnology company.